
August 26, 2009 –
Aegis Therapeutics and
Albany Medical College announced that they have expanded their existing research relationship, entering into a joint commercialization agreement to promote the clinical development of Albany Medical College’s patented anti-obesity peptide drug. Under this agreement, Aegis will be responsible for developing an appropriate partnership with a pharmaceutical company interested in commercializing this exciting new drug in the obesity and diabetes fields...
[PDF]Aegis Therapeutics' Press Release -